Medivir is a pharmaceutical company focusing on the development of innovative treatments for cancer.
Medivir focuses on cancers of high unmet medical need to provide benefit to patients who so far have had few treatment options.Our projects >
Medivir leverages collaborations with academic and industrial partners in order to bring specialty knowledge, experience and other capabilities to our projects.Partnership >
Medivir presents data that strengthens the fostrox/Lenvima combination in primary liver cancer at EASL Liver Cancer SummitRead more
MEDIVIR AB – YEAR-END REPORT JANUARY – DECEMBER 2023Read more
Number of shares and votes in Medivir AB on 31 January 2024Read more
Partnering is an important element of our business strategy. Together with our partners we have been successful in taking two products from research, through clinical development to launch on a global scale.